Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

Add To Watchlist

Recent & Breaking News (TSXV:THRM)

Therma Bright to Amend Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device

Newsfile April 3, 2018

Therma Bright Signs Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device

Newsfile March 14, 2018

Therma Bright Finalizes Terms on Acquisition, Adds Advisory Board Member and Grants Options

Newsfile March 2, 2018

Therma Bright Announces Completion of Debt Settlements

Newsfile February 16, 2018

Jenex Announces Continuation to BC and Name Change to "Therma Bright Inc."

Newsfile February 7, 2018

Jenex Announces Non-Binding Letter of Intent with Quinsam Capital Corp. for $250,000 Investment to Develop CBD and THC Related Thermal Therapy Technology for Pain Relief and Other Pain Related Applications

Newsfile February 1, 2018

Jenex Completes Due Diligence on Acquisition Targets

Newsfile January 30, 2018

The Jenex Corporation Announces Board Change; Appointment of Advisory Board, Debt Settlement and Option Grants

Newsfile January 17, 2018

Jenex's TherOZap(TM) Technology Indicates Effectiveness in Inhibiting Zika Virus After Pre-Clinical Study

Newsfile January 8, 2018

The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition

Newsfile December 12, 2017

The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets

Canadian Press, with file by Stockhouse November 3, 2017

The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)

Newsfile October 12, 2017

Jenex Reports Expected Date of Test Results for TherOZap at Inactivating the Zika Virus

Newsfile September 14, 2017

Jenex Reports Expected Date of Test Results for TherOZap(TM) at Inactivating the Zika Virus

Newsfile September 14, 2017

The Jenex Corporation Announces Conditional Acceptance of Reactivation from NEX to TSX Venture Exchange, TherOZap(TM) Testing and ISO 13485:2003 Update

Newsfile August 17, 2017

The Jenex Corporation Completes $317,500 Oversubscribed Non-Brokered Private Placement with Insider Participation

Newsfile June 21, 2017

The Jenex Corporation Announces Equity Financing with Insider Participation

Newsfile May 29, 2017

Jenex Finalizing Protocol to Test TherOZap(TM) Against the Zika Virus with University Health Network

Newsfile May 23, 2017

Jenex to Test Next Generation Technology, TherOZap(TM) Against the Zika Virus and West Nile Virus

Newsfile December 8, 2016

Jenex Announces TherOZap(TM), the Company's Next Generation Thermal Therapy Insect Device and Proposed Share for Debt Settlement Terms

Newsfile November 18, 2016